Aberrant recombination involving the granzyme locus occurs in Atm−/− T-cell lymphomas
Author(s) -
Christopher J. Winrow,
Daniel G. Pankratz,
Cecile Rose T. Vibat,
Timothy J. Bowen,
Marie Callahan,
Amy J. Warren,
Brian S. Hilbush,
Anthony WynshawBoris,
Karl W. Hasel,
Zoë Weaver Ohler,
David J. Lockhart,
Carrolee Barlow
Publication year - 2005
Publication title -
human molecular genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.811
H-Index - 276
eISSN - 1460-2083
pISSN - 0964-6906
DOI - 10.1093/hmg/ddi301
Subject(s) - biology , recombination , locus (genetics) , genetics , granzyme a , microbiology and biotechnology , cancer research , granzyme b , gene , t cell , immune system
Ataxia telangiectasia (A-T) is an autosomal recessive disease caused by loss of function of the serine/threonine protein kinase ATM (ataxia telangiectasia mutated). A-T patients have a 250-700-fold increased risk of developing lymphomas and leukemias which are typically highly invasive and proliferative. In addition, a subset of adult acute lymphoblastic leukemias and aggressive B-cell chronic lymphocytic leukemias that occur in the general population show loss of heterozygosity for ATM. To define the specific role of ATM in lymphomagenesis, we studied T-cell lymphomas isolated from mice with mutations in ATM and/or p53 using cytogenetic analysis and mRNA transcriptional profiling. The analyses identified genes misregulated as a consequence of the amplifications, deletions and translocation events arising as a result of ATM loss. A specific recurrent disruption of the granzyme gene family locus was identified resulting in an aberrant granzyme B/C fusion product. The combined application of cytogenetic and gene expression approaches identified specific loci and genes that define the pathway of initiation and progression of lymphoreticular malignancies in the absence of ATM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom